Gene Symbol | Gene ID | Gene Info |
---|---|---|
PRDM1
|
ENSG00000057657.10 | PR/SET domain 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_106474855_106475295 | PRDM1 | 59120 | 0.133971 | 0.49 | 1.8e-01 | Click! |
chr6_106531584_106531735 | PRDM1 | 2536 | 0.337820 | 0.44 | 2.4e-01 | Click! |
chr6_106533592_106533944 | PRDM1 | 427 | 0.872279 | 0.41 | 2.7e-01 | Click! |
chr6_106445374_106445525 | PRDM1 | 88746 | 0.084201 | 0.40 | 2.8e-01 | Click! |
chr6_106542111_106542262 | PRDM1 | 4295 | 0.259146 | 0.39 | 3.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_15390844_15391029 | 2.55 |
FAM171A1 |
family with sequence similarity 171, member A1 |
22122 |
0.25 |
chr10_52984247_52984441 | 1.96 |
RP11-40C11.2 |
|
21222 |
0.19 |
chr17_78044749_78045392 | 1.83 |
CCDC40 |
coiled-coil domain containing 40 |
12346 |
0.15 |
chr18_40710046_40710304 | 1.62 |
RIT2 |
Ras-like without CAAX 2 |
14518 |
0.31 |
chr16_65566073_65566543 | 1.59 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
410040 |
0.01 |
chr2_40506166_40506540 | 1.53 |
AC007377.1 |
|
18206 |
0.24 |
chr6_151392247_151392482 | 1.43 |
RP1-292B18.3 |
|
15171 |
0.18 |
chr10_61927237_61927410 | 1.34 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
669 |
0.8 |
chr4_99468302_99468540 | 1.34 |
RP11-724M22.1 |
|
50906 |
0.16 |
chr8_58660875_58661197 | 1.33 |
ENSG00000252057 |
. |
191892 |
0.03 |
chr13_21289085_21289250 | 1.33 |
ENSG00000265710 |
. |
11325 |
0.19 |
chr6_131290698_131290904 | 1.31 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
822 |
0.76 |
chr5_144624790_144624969 | 1.31 |
ENSG00000221467 |
. |
47541 |
0.21 |
chr2_151343410_151343893 | 1.28 |
RND3 |
Rho family GTPase 3 |
530 |
0.88 |
chr1_163039657_163039882 | 1.25 |
RGS4 |
regulator of G-protein signaling 4 |
618 |
0.82 |
chr11_104788188_104788675 | 1.25 |
RP11-693N9.2 |
|
7789 |
0.2 |
chrX_83618810_83618981 | 1.23 |
ENSG00000221494 |
. |
138059 |
0.05 |
chr4_160170135_160170337 | 1.23 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
17797 |
0.23 |
chr15_62916920_62917378 | 1.21 |
RP11-625H11.1 |
Uncharacterized protein |
20231 |
0.19 |
chr7_92325122_92325607 | 1.21 |
ENSG00000206763 |
. |
5764 |
0.28 |
chr11_2966476_2966712 | 1.21 |
PHLDA2 |
pleckstrin homology-like domain, family A, member 2 |
15909 |
0.11 |
chr8_123256270_123256596 | 1.21 |
ENSG00000238901 |
. |
427097 |
0.01 |
chr6_6005898_6006049 | 1.21 |
NRN1 |
neuritin 1 |
1227 |
0.56 |
chr13_41013314_41013519 | 1.21 |
ENSG00000252812 |
. |
31839 |
0.22 |
chr18_7460561_7460853 | 1.20 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
106073 |
0.07 |
chr12_65997242_65997414 | 1.18 |
HMGA2 |
high mobility group AT-hook 2 |
220583 |
0.02 |
chr1_174383473_174383626 | 1.18 |
GPR52 |
G protein-coupled receptor 52 |
33663 |
0.21 |
chr8_134203052_134203203 | 1.17 |
WISP1 |
WNT1 inducible signaling pathway protein 1 |
155 |
0.97 |
chr3_178787859_178788171 | 1.15 |
ZMAT3 |
zinc finger, matrin-type 3 |
1339 |
0.48 |
chr13_34061717_34062025 | 1.15 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
137104 |
0.05 |
chr12_120246787_120247132 | 1.14 |
CIT |
citron (rho-interacting, serine/threonine kinase 21) |
5772 |
0.26 |
chr6_132735691_132735842 | 1.13 |
MOXD1 |
monooxygenase, DBH-like 1 |
13082 |
0.25 |
chr3_187755166_187755324 | 1.13 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
115827 |
0.06 |
chr11_46307450_46307608 | 1.13 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
8301 |
0.18 |
chr4_126541169_126541320 | 1.12 |
FAT4 |
FAT atypical cadherin 4 |
226153 |
0.02 |
chr11_88914566_88914721 | 1.10 |
TYR |
tyrosinase |
4023 |
0.33 |
chr1_116920744_116920998 | 1.09 |
ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
4162 |
0.19 |
chr1_47119420_47119571 | 1.09 |
ATPAF1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
4904 |
0.15 |
chr2_161808984_161809250 | 1.07 |
ENSG00000244372 |
. |
75059 |
0.12 |
chr1_201914577_201914874 | 1.06 |
LMOD1 |
leiomodin 1 (smooth muscle) |
990 |
0.39 |
chr17_17863110_17863392 | 1.06 |
TOM1L2 |
target of myb1-like 2 (chicken) |
12460 |
0.15 |
chr2_191511664_191511958 | 1.02 |
NAB1 |
NGFI-A binding protein 1 (EGR1 binding protein 1) |
339 |
0.9 |
chr3_186822986_186823144 | 1.02 |
RPL39L |
ribosomal protein L39-like |
34207 |
0.17 |
chr1_180881031_180881376 | 1.01 |
KIAA1614 |
KIAA1614 |
1122 |
0.51 |
chr11_122072907_122073271 | 1.01 |
ENSG00000207994 |
. |
50073 |
0.12 |
chr9_2126015_2126202 | 1.01 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
31572 |
0.18 |
chr10_30209872_30210248 | 1.00 |
KIAA1462 |
KIAA1462 |
138393 |
0.05 |
chr10_117740714_117740886 | 1.00 |
GFRA1 |
GDNF family receptor alpha 1 |
274507 |
0.02 |
chr2_134484497_134484648 | 1.00 |
ENSG00000200708 |
. |
130910 |
0.05 |
chr1_219445701_219445873 | 0.99 |
RP11-135J2.4 |
|
98484 |
0.08 |
chr10_116157125_116157362 | 0.99 |
AFAP1L2 |
actin filament associated protein 1-like 2 |
6996 |
0.24 |
chr4_181928076_181928259 | 0.99 |
ENSG00000251742 |
. |
828094 |
0.0 |
chr4_87503159_87503484 | 0.98 |
MAPK10 |
mitogen-activated protein kinase 10 |
11942 |
0.21 |
chr5_57368325_57368559 | 0.98 |
ENSG00000238899 |
. |
2427 |
0.45 |
chr11_63713225_63713426 | 0.98 |
NAA40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
6605 |
0.12 |
chr1_23894994_23895239 | 0.97 |
ID3 |
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
8831 |
0.18 |
chr1_216692804_216692955 | 0.97 |
USH2A |
Usher syndrome 2A (autosomal recessive, mild) |
96141 |
0.09 |
chr14_22848856_22849106 | 0.97 |
ENSG00000251002 |
. |
52738 |
0.09 |
chr1_71831543_71831741 | 0.97 |
ENSG00000229956 |
. |
35763 |
0.23 |
chr5_158524974_158525234 | 0.96 |
EBF1 |
early B-cell factor 1 |
1597 |
0.48 |
chr15_83870418_83870820 | 0.96 |
HDGFRP3 |
Hepatoma-derived growth factor-related protein 3 |
6151 |
0.19 |
chr14_55194961_55195128 | 0.96 |
SAMD4A |
sterile alpha motif domain containing 4A |
26507 |
0.23 |
chr10_4093321_4093737 | 0.95 |
KLF6 |
Kruppel-like factor 6 |
266056 |
0.02 |
chr6_161860014_161860217 | 0.95 |
AGPAT4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
165022 |
0.04 |
chr9_113282590_113282762 | 0.95 |
ENSG00000212254 |
. |
19402 |
0.24 |
chr12_91533014_91533165 | 0.95 |
DCN |
decorin |
6896 |
0.25 |
chr10_121209276_121209427 | 0.94 |
GRK5 |
G protein-coupled receptor kinase 5 |
71402 |
0.09 |
chr5_87798376_87798680 | 0.94 |
TMEM161B-AS1 |
TMEM161B antisense RNA 1 |
76016 |
0.11 |
chr7_116332995_116333296 | 0.93 |
MET |
met proto-oncogene |
5994 |
0.27 |
chr12_76376819_76377254 | 0.93 |
ENSG00000243420 |
. |
25126 |
0.18 |
chr1_243517492_243517644 | 0.93 |
ENSG00000265201 |
. |
8090 |
0.26 |
chr9_75708779_75709072 | 0.92 |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
13567 |
0.27 |
chr5_14449868_14450019 | 0.92 |
TRIO |
trio Rho guanine nucleotide exchange factor |
38614 |
0.21 |
chr8_92988247_92988452 | 0.92 |
GS1-5L10.1 |
|
213 |
0.96 |
chr10_90966269_90966420 | 0.91 |
CH25H |
cholesterol 25-hydroxylase |
727 |
0.67 |
chr9_112542645_112542955 | 0.91 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
31 |
0.37 |
chr8_77585853_77586055 | 0.89 |
ZFHX4 |
zinc finger homeobox 4 |
7500 |
0.24 |
chr8_16645234_16645451 | 0.89 |
ENSG00000264092 |
. |
75663 |
0.12 |
chr7_25835612_25835941 | 0.89 |
ENSG00000199085 |
. |
153830 |
0.04 |
chr9_18490908_18491217 | 0.89 |
ADAMTSL1 |
ADAMTS-like 1 |
16831 |
0.27 |
chr2_143773567_143773818 | 0.88 |
ENSG00000221169 |
. |
10332 |
0.28 |
chr5_165798296_165798496 | 0.88 |
ENSG00000264903 |
. |
211871 |
0.03 |
chr19_55598672_55599034 | 0.88 |
EPS8L1 |
EPS8-like 1 |
7093 |
0.1 |
chr10_124222195_124222452 | 0.88 |
HTRA1 |
HtrA serine peptidase 1 |
1282 |
0.44 |
chr15_49760511_49761130 | 0.88 |
FGF7 |
fibroblast growth factor 7 |
45363 |
0.16 |
chr6_134212007_134212270 | 0.88 |
RP3-323P13.2 |
|
936 |
0.53 |
chr8_122274743_122274894 | 0.88 |
ENSG00000221644 |
. |
75686 |
0.12 |
chrY_21763188_21763339 | 0.87 |
TXLNG2P |
taxilin gamma 2, pseudogene |
4821 |
0.27 |
chr11_14467853_14468182 | 0.86 |
ENSG00000251991 |
. |
32421 |
0.18 |
chr18_50434264_50434415 | 0.86 |
DCC |
deleted in colorectal carcinoma |
26803 |
0.22 |
chr18_53526273_53526597 | 0.85 |
TCF4 |
transcription factor 4 |
194417 |
0.03 |
chr5_78858830_78859073 | 0.84 |
ENSG00000207391 |
. |
28275 |
0.18 |
chr3_152313885_152314285 | 0.84 |
RP11-362A9.3 |
|
99483 |
0.08 |
chr2_12129216_12129367 | 0.84 |
ENSG00000238503 |
. |
41207 |
0.19 |
chr6_49294723_49295128 | 0.84 |
ENSG00000252457 |
. |
17596 |
0.27 |
chr3_145616284_145616545 | 0.84 |
RP11-274H2.5 |
|
163052 |
0.04 |
chr18_53775687_53775874 | 0.84 |
ENSG00000201816 |
. |
28955 |
0.27 |
chr8_50826499_50826650 | 0.84 |
SNTG1 |
syntrophin, gamma 1 |
1869 |
0.53 |
chr2_98630005_98630391 | 0.84 |
TMEM131 |
transmembrane protein 131 |
17810 |
0.24 |
chr18_67834074_67834322 | 0.84 |
RTTN |
rotatin |
38764 |
0.21 |
chr11_131487348_131487499 | 0.83 |
NTM |
neurotrimin |
35518 |
0.18 |
chr22_28174315_28174484 | 0.83 |
MN1 |
meningioma (disrupted in balanced translocation) 1 |
23087 |
0.23 |
chr20_49465299_49465721 | 0.83 |
ENSG00000265062 |
. |
11935 |
0.18 |
chr1_78961568_78961719 | 0.83 |
PTGFR |
prostaglandin F receptor (FP) |
4886 |
0.31 |
chr13_32119960_32120148 | 0.83 |
RXFP2 |
relaxin/insulin-like family peptide receptor 2 |
193620 |
0.03 |
chr9_122707486_122707725 | 0.82 |
ENSG00000207814 |
. |
299723 |
0.01 |
chr11_111445251_111445475 | 0.82 |
SIK2 |
salt-inducible kinase 2 |
27752 |
0.11 |
chr10_131761561_131761767 | 0.81 |
EBF3 |
early B-cell factor 3 |
441 |
0.9 |
chr5_120534956_120535178 | 0.81 |
ENSG00000222609 |
. |
488532 |
0.01 |
chr2_199480864_199481015 | 0.81 |
ENSG00000252511 |
. |
49486 |
0.2 |
chr18_53167832_53168083 | 0.81 |
RP11-619L19.2 |
|
8551 |
0.19 |
chr3_121151020_121151375 | 0.80 |
POLQ |
polymerase (DNA directed), theta |
113656 |
0.06 |
chr10_34630198_34630349 | 0.80 |
PARD3 |
par-3 family cell polarity regulator |
31188 |
0.25 |
chrX_99900030_99900181 | 0.79 |
SRPX2 |
sushi-repeat containing protein, X-linked 2 |
890 |
0.57 |
chr6_47165564_47165740 | 0.79 |
TNFRSF21 |
tumor necrosis factor receptor superfamily, member 21 |
111989 |
0.07 |
chr6_88506291_88506649 | 0.79 |
ENSG00000207131 |
. |
29533 |
0.16 |
chr17_13486518_13486693 | 0.79 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
18639 |
0.23 |
chr7_16473361_16473576 | 0.78 |
ISPD |
isoprenoid synthase domain containing |
12521 |
0.23 |
chrX_83420601_83420752 | 0.78 |
RPS6KA6 |
ribosomal protein S6 kinase, 90kDa, polypeptide 6 |
22239 |
0.25 |
chr8_11349538_11349737 | 0.78 |
BLK |
B lymphoid tyrosine kinase |
1873 |
0.29 |
chr2_205920685_205921182 | 0.78 |
PARD3B |
par-3 family cell polarity regulator beta |
510210 |
0.0 |
chr14_65273817_65273968 | 0.77 |
SPTB |
spectrin, beta, erythrocytic |
15920 |
0.19 |
chr4_87373379_87373575 | 0.77 |
MAPK10 |
mitogen-activated protein kinase 10 |
806 |
0.74 |
chr2_16831792_16832248 | 0.77 |
FAM49A |
family with sequence similarity 49, member A |
15076 |
0.3 |
chr6_11231077_11231290 | 0.77 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
1708 |
0.44 |
chr7_132765840_132766055 | 0.76 |
CHCHD3 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
853 |
0.59 |
chr4_159574164_159574322 | 0.76 |
C4orf46 |
chromosome 4 open reading frame 46 |
18801 |
0.16 |
chr4_86745352_86745503 | 0.76 |
ARHGAP24 |
Rho GTPase activating protein 24 |
3471 |
0.34 |
chr5_80690086_80690663 | 0.76 |
ACOT12 |
acyl-CoA thioesterase 12 |
376 |
0.91 |
chr14_55796796_55797030 | 0.76 |
RP11-665C16.5 |
|
9306 |
0.24 |
chr2_145753160_145753596 | 0.76 |
ENSG00000253036 |
. |
339260 |
0.01 |
chr5_102203960_102204196 | 0.76 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
2258 |
0.46 |
chr6_12279974_12280135 | 0.75 |
EDN1 |
endothelin 1 |
10542 |
0.3 |
chr4_124776288_124776439 | 0.75 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
455240 |
0.01 |
chr8_95273934_95274493 | 0.75 |
GEM |
GTP binding protein overexpressed in skeletal muscle |
360 |
0.91 |
chr18_30310087_30311054 | 0.75 |
AC012123.1 |
Uncharacterized protein |
39188 |
0.17 |
chr20_44699432_44699601 | 0.75 |
NCOA5 |
nuclear receptor coactivator 5 |
19075 |
0.14 |
chr1_214491340_214491539 | 0.75 |
SMYD2 |
SET and MYND domain containing 2 |
12881 |
0.25 |
chr4_138463714_138463954 | 0.75 |
PCDH18 |
protocadherin 18 |
10186 |
0.33 |
chr17_11852046_11852277 | 0.75 |
RP11-1096G20.5 |
|
28750 |
0.16 |
chr10_4425832_4426362 | 0.74 |
ENSG00000207124 |
. |
131047 |
0.06 |
chr6_21916023_21916204 | 0.74 |
ENSG00000222515 |
. |
169660 |
0.04 |
chr8_119115834_119115985 | 0.74 |
EXT1 |
exostosin glycosyltransferase 1 |
6744 |
0.34 |
chr10_51811950_51812150 | 0.74 |
RP11-324H6.5 |
|
11086 |
0.19 |
chr6_99212409_99212624 | 0.73 |
POU3F2 |
POU class 3 homeobox 2 |
70064 |
0.14 |
chr2_199639717_199640158 | 0.73 |
ENSG00000252511 |
. |
208484 |
0.03 |
chr3_99679363_99679603 | 0.73 |
ENSG00000264897 |
. |
3759 |
0.33 |
chr21_18376217_18376955 | 0.72 |
ENSG00000239023 |
. |
285269 |
0.01 |
chr11_43598101_43598272 | 0.72 |
ENSG00000199077 |
. |
4758 |
0.24 |
chr13_31271674_31272060 | 0.72 |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
37778 |
0.19 |
chr11_32383224_32383375 | 0.72 |
WT1 |
Wilms tumor 1 |
38862 |
0.19 |
chr1_208260069_208260332 | 0.72 |
PLXNA2 |
plexin A2 |
157465 |
0.04 |
chr2_52632101_52632252 | 0.72 |
ENSG00000202195 |
. |
107043 |
0.08 |
chr15_44485809_44485960 | 0.71 |
FRMD5 |
FERM domain containing 5 |
760 |
0.75 |
chr4_140737330_140737550 | 0.71 |
ENSG00000252233 |
. |
21853 |
0.23 |
chr11_85429919_85430085 | 0.71 |
SYTL2 |
synaptotagmin-like 2 |
123 |
0.96 |
chr8_97505496_97505647 | 0.71 |
SDC2 |
syndecan 2 |
8 |
0.99 |
chr13_102965778_102965929 | 0.71 |
FGF14-AS1 |
FGF14 antisense RNA 1 |
54036 |
0.15 |
chr18_42366702_42366923 | 0.70 |
SETBP1 |
SET binding protein 1 |
89683 |
0.1 |
chr12_68246942_68247109 | 0.70 |
IFNG-AS1 |
IFNG antisense RNA 1 |
136200 |
0.05 |
chr7_84198152_84198303 | 0.70 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
76187 |
0.12 |
chr14_54605059_54605210 | 0.70 |
BMP4 |
bone morphogenetic protein 4 |
179655 |
0.03 |
chr5_54834427_54834797 | 0.69 |
PPAP2A |
phosphatidic acid phosphatase type 2A |
3734 |
0.27 |
chr5_111952744_111952991 | 0.69 |
APC |
adenomatous polyposis coli |
90328 |
0.09 |
chr1_161932087_161932899 | 0.69 |
OLFML2B |
olfactomedin-like 2B |
22529 |
0.22 |
chr11_96438289_96438578 | 0.69 |
ENSG00000200411 |
. |
230577 |
0.02 |
chr22_40672320_40672471 | 0.69 |
TNRC6B |
trinucleotide repeat containing 6B |
11388 |
0.23 |
chr7_19155354_19155672 | 0.68 |
TWIST1 |
twist family bHLH transcription factor 1 |
1782 |
0.28 |
chr1_59522619_59522770 | 0.68 |
FGGY |
FGGY carbohydrate kinase domain containing |
239616 |
0.02 |
chr12_76426636_76426787 | 0.68 |
PHLDA1 |
pleckstrin homology-like domain, family A, member 1 |
1001 |
0.51 |
chr9_118917834_118918063 | 0.68 |
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
1865 |
0.44 |
chr6_170768539_170768975 | 0.68 |
RP1-140C12.2 |
|
45530 |
0.15 |
chr2_128491483_128491650 | 0.68 |
SFT2D3 |
SFT2 domain containing 3 |
32969 |
0.13 |
chr11_88390713_88390864 | 0.68 |
ENSG00000207113 |
. |
44709 |
0.2 |
chr17_77042563_77042714 | 0.67 |
C1QTNF1 |
C1q and tumor necrosis factor related protein 1 |
2963 |
0.2 |
chr2_136598368_136598551 | 0.67 |
LCT |
lactase |
3709 |
0.2 |
chr2_67801375_67801526 | 0.67 |
ETAA1 |
Ewing tumor-associated antigen 1 |
176999 |
0.03 |
chr12_17794706_17795007 | 0.67 |
ENSG00000206662 |
. |
69012 |
0.15 |
chr10_53627774_53628104 | 0.67 |
CSTF2T |
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant |
168584 |
0.04 |
chr1_70916763_70916914 | 0.67 |
CTH |
cystathionase (cystathionine gamma-lyase) |
39772 |
0.17 |
chr4_184797459_184798247 | 0.67 |
STOX2 |
storkhead box 2 |
28656 |
0.22 |
chr3_120003475_120003938 | 0.67 |
GPR156 |
G protein-coupled receptor 156 |
235 |
0.94 |
chr15_74657875_74658107 | 0.66 |
CTD-2311M21.3 |
|
215 |
0.75 |
chr5_140430825_140431264 | 0.66 |
PCDHB1 |
protocadherin beta 1 |
65 |
0.96 |
chr4_19264306_19264465 | 0.66 |
ENSG00000251816 |
. |
80906 |
0.12 |
chr17_56310096_56310247 | 0.66 |
LPO |
lactoperoxidase |
5616 |
0.14 |
chr9_110400851_110401256 | 0.66 |
ENSG00000202308 |
. |
24474 |
0.24 |
chr5_89167593_89167744 | 0.66 |
ENSG00000264342 |
. |
144869 |
0.05 |
chr6_134494547_134494698 | 0.65 |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
1380 |
0.45 |
chr4_89730559_89730710 | 0.65 |
FAM13A |
family with sequence similarity 13, member A |
13718 |
0.24 |
chr18_72509515_72509666 | 0.65 |
ZNF407 |
zinc finger protein 407 |
166614 |
0.04 |
chr5_60599280_60599578 | 0.65 |
ZSWIM6 |
zinc finger, SWIM-type containing 6 |
28671 |
0.23 |
chr1_198092217_198092386 | 0.65 |
NEK7 |
NIMA-related kinase 7 |
33792 |
0.24 |
chr6_128799339_128799870 | 0.65 |
RP1-86D1.5 |
|
22068 |
0.14 |
chr18_19481957_19482108 | 0.65 |
ENSG00000252325 |
. |
22270 |
0.15 |
chr3_105656990_105657196 | 0.64 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
68697 |
0.15 |
chr20_58004477_58004645 | 0.64 |
ENSG00000263903 |
. |
83026 |
0.09 |
chr9_80985944_80986319 | 0.64 |
PSAT1 |
phosphoserine aminotransferase 1 |
74072 |
0.12 |
chr7_84292969_84293132 | 0.64 |
ENSG00000265050 |
. |
2274 |
0.47 |
chr7_105134630_105134781 | 0.64 |
PUS7 |
pseudouridylate synthase 7 homolog (S. cerevisiae) |
13877 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.3 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.4 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.1 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.4 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.3 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.8 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.6 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.9 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.2 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.4 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.2 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.2 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.3 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0052167 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.0 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.6 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.3 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.0 | 0.1 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.0 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.1 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:1903670 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.1 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.0 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.0 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.2 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.0 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.0 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.0 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 1.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 2.4 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.0 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.5 | GO:0042552 | myelination(GO:0042552) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.2 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.0 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.0 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.0 | 0.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.5 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.2 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.2 | GO:1900076 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.0 | 0.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.0 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.2 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.2 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0044304 | main axon(GO:0044304) |
0.0 | 1.5 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 5.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 1.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 1.1 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.2 | GO:0016234 | inclusion body(GO:0016234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.3 | 0.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 2.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.6 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.2 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.7 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 1.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.2 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 1.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 1.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 2.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 2.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 3.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 4.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |